OTIC Otonomy Inc

Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear.

As of 05/14/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/13/2014
Outstanding shares:  56,618,092
Average volume:  392,479
Market cap:   $118,897,993
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68906L105
ISIN:        US68906L1052
Sedol:      BPVNJF0
Valuation   (See tab for details)
PE ratio:   -2.59
PB ratio:   1.79
PS ratio:   585.70
Return on equity:   -80.64%
Net income %:   -22,255.17%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy